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Abstract 
Background: Necroptosis is a newly identified type of programmed cell death that differs from apoptosis. Recent 
studies have demonstrated that necroptosis is involved in multiple pathologies of various human diseases. Receptor-
interacting protein 3 (RIP3) is known to be a critical regulator of necroptosis. This study investigated alterations in the 
RIP3 expression and the involvement in neural tissue damage after spinal cord injury (SCI) in mice.
Results: Immunohistochemical analysis demonstrated that the RIP3 expression was significantly increased in the 
lesion site after spinal cord hemisection. The increased expression of RIP3 started at 24 h, peaked at 3 days and lasted 
for at least 21 days after hemisection. The RIP3 expression was observed in neurons, astrocytes and oligodendrocytes. 
Western blot analysis also demonstrated the RIP3 protein expression significantly upregulated in the injured spinal 
cord. RIP3 staining using propidium iodide (PI)-labeled sections showed most of the PI-labeled cells were observed 
as RIP3-positive. Double staining of TUNEL and RIP3 demonstrated that TUNEL-positive cells exhibiting shrunken or 
fragmented nuclei, as generally observed in apoptotic cells, rarely expressed RIP3.
Conclusions: The present study first demonstrated that the expression of RIP3 is dramatically upregulated in vari-
ous neural cells in the injured spinal cord and peaked at 3 days after injury. Additionally, most of the PI-labeled cells 
expressed RIP3 in response to neural tissue damage after SCI. The present study suggested that the upregulation of 
the RIP3 expression may play a role as a novel molecular mechanism in secondary neural tissue damage following SCI. 
However, further study is needed to clarify the specific molecular mechanism underlying the relationship between 
the RIP3 expression and cell death in the injured spinal cord.
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Background
Necrosis was originally thought to be a purely passive 
and uncontrolled type of cell death. Necrosis, which is 
marked by cell swelling and membrane rupture, leads 
to inflammation via the release of intracellular signals 
[1–3]. In contrast, apoptosis, which is characterized by 
the activation of caspases and DNA fragmentation, was 
once considered the sole form of programmed cell death. 
Chromatin condensation, nuclear shrinkage and frag-
mentation and membrane blebbing are the result of the 
proteolytic activity of caspases and define the morpho-
logical characteristics of apoptosis [3–5].
“Necroptosis” is a newly identified type of programmed 
necrosis. Necroptosis is another form of programmed 
cell death that is regulated by the caspase-independ-
ent pathway and exhibits the morphological features 
of necrosis [6, 7]. Recent studies have shown that the 
receptor-interacting protein (RIP) family is specifically 
involved in regulating necroptosis [3]. RIP3, a member of 
the RIP family, is known to be a key mediator of necrop-
tosis [8, 9]. RIP3 acts a nucleocytoplasmic shuttling pro-
tein and can locate not only in the cytoplasm but nucleus 
[10]. Various stimuli to cells can induce the formation of 
necrotic complexes that contain RIP1, TRADD, FADD 
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and caspase-8. The interaction of RIP3 with RIP1 in the 
necrotic complex is an important step required for the 
execution of necroptosis [3, 11]. Previous studies have 
demonstrated that the RIP3 expression correlates with 
the induction of necroptosis in various types of cells 
[12–18]. RIP3 alone can trigger necroptosis, even in the 
absence of RIP1 [12, 14, 19]. Therefore, RIP3 is indispen-
sable for necroptosis, whereas RIP1 may participate only 
in certain stimulus-induced types of cell necroptosis [9].
Furthermore, recent studies have shown an increased 
expression of RIP3 in lesions and the induction of 
necroptosis in various disease models [18, 20], such as 
that involving liver injury [14], ileitis [21], skin inflam-
mation [22], and kidney ischemia–reperfusion injury 
[23]. The expression of RIP3 is also increased in retinal 
neurons in response to acute ischemic insults [24], and 
the upregulation of RIP3 contributes to the induction of 
necroptotic cell death in hippocampal neurons following 
cerebral ischemia [17].
Currently, it is considered that secondary damage after 
spinal cord injury (SCI) is caused by apoptosis, and most 
previous research related to cell death in the injured spi-
nal cord has focused on apoptosis, not necroptosis.
In the present study, we investigated alterations in the 
RIP3 protein expression and the involvement of necrop-




All experimental procedures were approved by the Insti-
tutional Animal Care and Use Committee of Tohoku 
University. All efforts were made to minimize the num-
ber of animals used and to decrease their suffering. Adult 
female C57BL/6J mice (8–10  weeks old; Charles River, 
Japan Inc., Yokohama, Japan) were used in this study. The 
mice were housed three or four per cage and kept at a 
temperature of 24 °C with free access to food and water 
before and after surgery.
Spinal cord hemisection model
The mice were anesthetized with 2  % sevoflurane. A 
15-mm midline skin incision was made, and the laminae 
of T9-11 were exposed. Laminectomy was performed 
at the thoracic vertebra at T10, exposing the dorsal sur-
face of the spinal cord without disrupting the dura mater. 
With a sharp scalpel, the spinal cord was hemi-transected 
on the left side only [25–28]. In mice with a compro-
mised bladder function (a rare complication), the blad-
der was manual expressed twice a day until spontaneous 
voiding was noted. The sham-operated animals under-
went the same surgical procedures, although hemisection 
was not applied to the spinal cord. During the surgery, 
the rectal temperature was monitored and maintained at 
37.0 ± 0.5 °C with a heating pad.
Tissue preparation
At different time points (4 h, 24 h, 3, 7, and 21 days) after 
hemisection and immediately after the sham operation, 
the mice were overdosed via an intraperitoneal injection 
of 100  mg/kg sodium pentobarbital. The mice were then 
transcardially perfused with normal saline, followed by 
4 % paraformaldehyde in 0.1 M PBS, pH 7.4. For immuno-
histochemical staining, the spinal cord segments contain-
ing the injured site were collected, postfixed in the same 
fixative overnight at 4  °C, cryoprotected in 30  % sucrose 
in PBS for 48 h at 4 °C and embedded in Optimal-Cutting-
Temperature compound (Sakura Finetek, Japan). Serial 
15-μm transverse cryostat sections obtained from around 
the injured site were mounted on slides. A total of 13 
sequential sections were collected at 250-μm intervals that 
spanned 3000 μm in length along the spinal cord centered 
at the epicenter. The sections were used for both immuno-
histochemical and TUNEL staining, as described below.
Immunohistochemical staining of RIP3
For the immunohistochemical staining of RIP3, the sec-
tions were washed in PBS for 15  min, after which they 
were washed with PBS containing 0.3 % Tween for 10 min 
and blocked with 3 % milk and 5 % FBS in 0.01 M PBS for 
2  h. The sections were incubated with rabbit anti-RIP3 
antibodies (1:100; Sigma-Aldrich) diluted in PBS over-
night at 4  °C. After rinsing with PBS, the sections were 
incubated with secondary antibodies. The sections were 
coverslipped with Vectashield containing DAPI to label 
the nuclei (Vector Laboratories). In each experiment, the 
sections were stained at the same time.
Counting and calculation of RIP3‑positive cells
Following immunochemical staining of RIP3, as 
described above, each section was scanned using a fluo-
rescence microscope (BX 51; Olympus, Tokyo, Japan). In 
order to quantify the RIP3 expression in the spinal cord, 
the total number of RIP3-positive cells in the injured and 
contralateral sides of the spinal cord was counted using 
the serial transverse sections at 250-μm intervals. The 
sections with the highest number of RIP3-positive cells 
on the injured side and the 250-μm rostral and caudal 
sections in each animal were selected. Then, the sum of 
the numbers in the three sections was compared between 
the injured side, the contralateral side and the sham 
group.
Western blot analysis of RIP3
The mice were killed 3  days after spinal cord hemisec-
tion and the sham operation, and their spinal cords were 
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removed. The spinal cord was homogenized in lysis 
buffer. The debris was removed via centrifugation, and 
the protein levels in the lysates were determined with 
the aid of a Bio-Rad protein assay (Bio-Rad Laboratories, 
USA). The protein (30  μg) in the lysates was resolved 
using SDS–polyacrylamide gel electrophoresis (PAGE) 
in 15  % gels and then electrophoretically transferred to 
a polyvinylidene difluoride membrane. The membranes 
were blocked for 1  h in TBST buffer (0.01  M Tris HCl, 
pH 7.5, 0.15  M NaCl and 0.05  % Tween 20) containing 
3 % milk and incubated with rabbit anti-RIP3 antibodies 
(1:100; Santa Cruz Biotechnology, USA) diluted in TBST 
buffer overnight at 4 °C. The membranes were incubated 
with secondary antibodies linked to horseradish per-
oxidase (1:1000; Invitrogen). The immunoreactive bands 
were developed using the enhanced chemiluminescence 
reagent (Amersham Corp). The band density was quan-
tified using a scanned densitometric analysis and the 
Image Lab software program version 4.1 (Bio-Rad Labo-
ratories). The quantity of the band density was normal-
ized according to the level of β-tubulin and compared 
between the injured and uninjured spinal cord samples.
Double staining for RIP3 and various cell type markers
In order to examine the expression of RIP3 in a specific 
population of cells, the transverse sections obtained 
3  days after hemisection were double-stained for RIP3 
and various cell type markers: NeuN for neurons, GFAP 
for astrocytes and Olig2 for oligodendrocytes. The sec-
tions were incubated with a mixture of rabbit anti-
RIP3 antibody (1:100; Sigma-Aldrich) and either goat 
anti-Olig2 (1:100; Santa Cruz Biotechnology), mouse 
anti-GFAP (1:50; Dako) or mouse anti-NeuN (1:100; 
Chemicon) antibodies diluted in PBS overnight at 4  °C. 
After rinsing with PBS, the sections were incubated with 
secondary antibodies, and then mounted with Vectash-
ield containing DAPI to label the nuclei (Vector Labora-
tories). The specificity of the RIP3 antibody was evaluated 
by omission of the primary antibody in immunohisto-
chemistry. Omitting the primary antibody (no primary 
immunoglobulin G control) in this protocol abrogated 
the staining, demonstrating the specificity of the immu-
noreactive staining [14, 24].
RIP3 staining using propidium iodide‑labeled spinal cord 
sections
In order to detect plasmalemma permeability, which is 
a hallmark of necrotic cell death, in the injured spinal 
cord at 3  days after hemisection, propidium iodide (PI) 
labeling was performed as previously described [29–31]. 
Briefly, PI (10  mg/mL; Sigma-Aldrich) was diluted in 
0.1  mL of PBS and then intraperitoneally injected at a 
dose of 1 mg/kg body weight at 1 h before sacrifice. The 
mice were transcardially perfused, and the spinal cords 
were collected and sectioned as described above. For 
immunohistochemical detection of the RIP3 expres-
sion in the PI-labeled cells, the PI-labeled spinal cord 
transverse sections were stained for RIP3, as outlined 
above. Using a fluorescence microscope (BX 51; Olym-
pus, Tokyo, Japan), the propidium iodide labeling was 
detected using emission and excitation wavelengths of 
568 and 585 nm, respectively.
Double staining of RIP3 and TUNEL
In order to identify DNA fragmentation in the cells 
expressing RIP3, double staining of RIP3 and terminal 
deoxynucleotidyl transferase-mediated dUTP nick end 
labeling (TUNEL) was performed using the transverse 
sections at 3  days after hemisection. Following immu-
nohistochemical staining of RIP3, as described above, 
the TUNEL was performed using the In Situ Cell Death 
Detection Kit (Roche Diagnostics).
Statistical analysis
Significant differences in the number of RIP3-positive 
cells and the band density of the Western blots were ana-
lyzed using the unpaired t test. In all analyses, a p value of 
<0.05 was considered to be statistically significant.
Results
Immunohistochemical staining for RIP3
The number of cells expressing RIP3 was increased on 
the injured side at 3  days after spinal cord hemisection 
(Fig.  1). Cells expressing RIP3 were observed in both 
the gray and white matter of the injured side. However, 
all cells on the injured side did not express RIP3. On the 
contralateral side, the number of cells expressing RIP3 
was obviously low, similar to that observed in the sham 
group.
Time course of the RIP3 expression after hemisection
Representative pictures showed that the number of cells 
expressing RIP3 was increased on the injured side at each 
time point after hemisection compared to that observed 
in the sham group (Fig.  2). The population of cells 
expressing RIP3 on the injured side was relatively larger 
at 3 and 7 days compared to that noted at the other time 
points.
When counting the number of RIP3-positive cells 
(Fig. 3), those observed on the injured side were found to 
be significantly higher than those seen on the contralat-
eral side and in the sham control group. A significant 
increase in the number of RIP3-positive cells was first 
noted at 24 h and lasted for at least 21 days (P < 0.05). The 
maximum number of RIP3-positive cells on the injured 
side was observed at 3 days after hemisection.
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Western blot analysis of RIP3
In the Western blot analysis, the level of RIP3 proteins 
was significantly higher in the injured spinal cord than 
in the uninjured spinal cord (Fig.  4a). In the analysis of 
the band density, the RIP3 expression was 2.2 ± 0.5-fold 
higher in the injured spinal cord (Fig. 4b, P = 0.005).
Double staining of RIP3 and various cell type markers
In order to examine the RIP3 expression in specific popu-
lations of cells, the transverse sections obtained at 3 days 
after hemisection were double-stained for RIP3 and vari-
ous neural cell type markers. On the double staining, the 
expression of RIP3 was observed in the NeuN-, GFAP- 
and Olig2-labeled cells (Fig. 5). The double staining dem-
onstrated the RIP3 expression in neurons, astrocytes 
and oligodendrocytes. However, not all of these cells 
expressed RIP3.
RIP3 expression in the PI‑labeled cells
Plasmalemma permeability, a hallmark of necrotic cell 
death, including necroptosis, was detected using PI-labe-
ling in  vivo. In RIP3 immunostaining using PI-labeled 
spinal cord sections. The number of both PI-labeled cells 
and RIP3-expressing cells increased on the injured side, 
and the PI-labeled cells were frequently observed to be 
RIP3-positive (Fig.  6). At a higher magnification, most 
of the nuclei in the PI-labeled cells expressing RIP3 were 
round, as generally observed in necrotic cell death.
Double staining of RIP3 and TUNEL
In order to detect DNA fragmentation in the cells express-
ing RIP3, we performed double staining of RIP3 and 
TUNEL. On the injured side, the numbers of TUNEL-pos-
itive and RIP3-positive cells were observed to have obvi-
ously increased (Fig. 7a–c). However, the RIP3 expression 
was rarely observed in the TUNEL-positive cells. Under 
higher magnification, most of the TUNEL-positive cells 
exhibiting shrunken or fragmented nuclei, as is typical of 
apoptotic cells, did not express RIP3 (Fig. 7d–f).
Discussions
In the present study, the level of RIP3 proteins significantly 
increased on the injured site after spinal cord hemisec-
tion. An increase in the number of RIP3-positive cells at 
Fig. 1 Immunohistochemical staining of RIP3 using spinal cord sections obtained 3 days after hemisection and the sham operation. The uninjured 
spinal cords in the sham operated mice (a, c) showed no obvious RIP3 expression. In contrast, a higher expression of RIP3 was observed on the 
injured side (L) than on the contralateral side (R) in the transverse (b) and coronal (d) sections after hemisection. Scale bars 500 μm
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Fig. 2 Immunohistochemical staining of RIP3 on the injured side in the transverse sections obtained at different time points. The expression of RIP3 
was not observed at 4 h (e–h); however, it started to increase at 24 h (i–l), in comparison to that observed in the sham group (a–d). The population 
of RIP3-expressing cells was obviously larger at 3 and 7 days (m–t) than at the other time points. Scale bars 100 μm (a–c, e–g, j–k, m–o, q–s, u–w), 
20 μm (d, h, l, p, t, x). The schematic drawing illustrates the location of the micrographs (y)
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the injured site was observed starting at 24  h, peaked at 
3 days and lasted for at least 21 days after injury. The RIP3 
expression was observed in neurons, astrocytes and oligo-
dendrocytes. Most of the PI-labeled cells expressed RIP3 in 
response to neural tissue damage after SCI. These results 
suggest that the expression of RIP3 was dramatically upreg-
ulated in various neural cells and may be involved in the 
pathological mechanism at the lesion site following SCI.
Traditionally, secondary damage of neural tissue fol-
lowing SCI has been considered to be caused by apop-
tosis, not necroptosis. Most previous research related to 
cell death in the injured spinal cord has focused on apop-
tosis. In the present study, both immunohistochemistry 
and Western blot analysis demonstrated that the RIP3 
expression was significantly upregulated at the lesion site 
after SCI. Importantly, the upregulation of the RIP3 pro-
tein was observed starting at 24 h, after which it peaked 
at 3  days and lasted for 21  days after injury. The time 
course of the RIP3 expression is quite similar to that of 
secondary damage following SCI [32–34]. Additionally, 
Fig. 3 Number of RIP3-positive cells on the injured and contralateral 
sides at different time points. The number of RIP3-positive cells on 
the injured side (L) was significantly higher than that observed on 
the contralateral side (R) and in the sham group at 24 h and 3, 7 and 
21 days. (*p < 0.05, n = 3 per each group). The values are presented 
as the mean ± SD
Fig. 4 RIP3 protein expression at 3 days after hemisection. a Western 
blotting showed that the RIP3 protein expression in the injured 
spinal cord was obviously increased compared to that observed in 
the uninjured spinal cord after the sham operation. b A quantitative 
analysis of the Western blots showed that the level of RIP3 proteins 
in the injured spinal cord was significantly higher than that observed 
in the sham control samples (*p < 0.05, n = 5 per each group). The 
quantity of the band density was normalized according to the level of 
β-tubulin. The values are presented as the mean ± SD
Fig. 5 Double staining for RIP3 and various cell type markers on the 
injured side in the transverse sections after hemisection. The RIP3 
expression was observed in the NeuN-, GFAP- and Olig2-labeled cells 
(arrowheads), demonstrating that the RIP3 expression was increased 
in neurons, astrocytes and oligodendrocytes, respectively. Scale bars: 
100 μm (a–c, g–i, m–o), 50 μm (d–f, j–l, p–r). The schematic drawing 
illustrates the location of the micrographs (s)
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we have previously confirmed that the number of 
TUNEL-positive cells peaked at 3  days in the thoracic 
spinal cord hemisection model in mice (data not shown). 
The TUNEL-positivity potentially indicates apoptotic cell 
death as well as necrotic cell death if the morphological 
characteristics of the cells are ignored [35]. Whalen et al. 
[31] suggested that different phenotypes of cell death can 
occur at the lesion site after the CNS injury. These find-
ings suggest that the increased expression of RIP3 in the 
injured spinal cord may contribute to secondary neural 
tissue damage and is possibly associated with not only 
apoptosis, but also necrotic cell death after SCI.
Recent studies have demonstrated that necropto-
sis plays a role in various pathological conditions in the 
CNS. Necroptosis can contribute to neural tissue damage 
in the model of adult brain ischemia [17, 36, 37], neonatal 
hypoxia–ischemia [38], traumatic brain injury [29] and 
neurodegenerative diseases [39, 40]. Retinal ischemia [24, 
41] and photoreceptor loss-associated retinal disorders 
[42] also involve neuronal necroptosis. Previous stud-
ies have shown that apoptosis is associated with peculiar 
morphological traits, including chromatin condensa-
tion and nuclear shrinkage and fragmentation, as well as 
blebbing of the intact plasma membrane and shedding 
of vacuoles containing cytoplasmic portions known as 
apoptotic bodies [1, 4, 5]. On the other hand, necropto-
sis involves a similar morphology to that of necrosis, such 
as minor ultrastructural modifications of the nucleus 
(dilatation of the nuclear membrane), osmotic swelling 
of organelles, an increased cell volume and breakdown of 
Fig. 6 Immunostaining for RIP3 using propidium iodide (PI)-labeled sections obtained 3 days after hemisection. The representative pictures show 
that the PI-labeled cells were frequently observed to be RIP3-positive (a–c). At higher magnification (d–f), most of the nuclei in the PI-labeled cells 
expressing RIP3 (arrowheads in f) were round, which is normally observed in cells undergoing necrotic cell death, not fragmented or shrunken, as 
observed in apoptotic cells. Scale bars 100 μm (a–c), 20 μm (d–f). The schematic drawing illustrates the location of the micrographs (g)
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the plasma membrane [3, 11]. In the present study, most 
of the PI-positive cells expressed RIP3 in the injured spi-
nal cord and contained round nuclei, which is generally 
observed in cells undergoing necrotic cell death. Addi-
tionally, the TUNEL-positive cells exhibiting shrunken 
or fragmented nuclei rarely expressed RIP3 at the lesion 
site. Based on the increased expression of RIP3 and the 
morphology of the nuclei in these cells, necroptosis may 
be one of the several types of cell deaths occurring in the 
injured spinal cord.
However, it has been reported that the PI- or TUNEL-
positivity cannot perfectly differentiate between necrotic 
and apoptotic cells. A previous study suggested that 
PI-positive cells can occasionally be TUNEL-positive 
after CNS injury [31]. The PI-positivity is a hallmark of 
necrosis, but cannot be used by itself to identify necrotic 
cells because PI can enter cells with activated pannexin 
channels [43]. The TUNEL-positivity potentially indi-
cates apoptotic cell death as well as necrotic cell death 
[35]. Additionally, the PI- or TUNEL-positivity did not 
perfectly reflect the RIP3 expression in the lesion site 
after hemisection in this study. Thus, from the data pre-
sented in this study, no firm conclusion about cell death 
in the RIP3-positive cells in the injured spinal cord can 
be made. The precise molecular mechanism underlying 
the relationship between RIP3 expression and PI- and/or 
TUNEL-positivity in neural tissue damage requires fur-
ther clarification.
Previous studies have suggested that necroptosis is 
induced in various neural cells. The RIP3 expression 
Fig. 7 Double staining for RIP3 and TUNEL on the injured side in transverse sections obtained 3 days after hemisection. The numbers of RIP3-
expressing and TUNEL-positive cells were obviously increased in the injured spinal cord (a–c). At higher magnification (d–f), the TUNEL-positive cells 
exhibiting shrunken or fragmented nuclei (arrowheads), a hallmark of apoptotic cell death, rarely expressed RIP3. Scale bars 100 μm (a–c), 20 μm 
(d–f). The schematic drawing illustrates the location of the micrographs (g)
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in retinal neurons is upregulated in response to acute 
ischemic insults [24], and cerebral ischemia induces 
necroptotic cell death in hippocampal neurons [17]. 
In addition, necroptosis drives motor neuron death in 
amyotrophic lateral sclerosis ALS [40], Furthermore, 
hemin induces necroptotic cell death in cortical astro-
cyte cultures [44]. Necroptosis is induced in cultured rat 
astrocytes by the administration of staurosporine [45] 
Necroptosis contributes to arachidonic acid-induced 
oxidative cell death in primary oligodendrocyte precur-
sor cultures [46]. According to our results, the expression 
of RIP3 is observed in neurons, astrocytes and oligoden-
drocytes in the injured spinal cord. These findings sug-
gested that necroptosis may occur in various neural cells 
and may contribute to multiple pathological mechanisms 
after SCI. However, the molecular mechanisms defining 
the features of necroptosis are not fully understood, and 
the precise pathological mechanisms induced by necrop-
tosis after SCI remain unclear. Further studies to clarify 
the molecular and biological mechanisms of necroptosis 
will hopefully lead to the development of novel therapeu-
tic strategies for the treatment of SCI.
Conclusion
In the present study, the expression of RIP3 is dramati-
cally increased at the lesion site after SCI. The increased 
RIP3 expression was observed in neurons, astrocytes and 
oligodendrocytes. Most of the PI-labeled cells expressed 
RIP3 in response to neural tissue damage. This study is the 
first to provide evidence supporting the increased expres-
sion of RIP3 involved in neural tissue damage after SCI.
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